2012 Global Rabies Diagnostics Market Outlook: Test Volumes, Sales Forecasts, and Supplier Shares by CountryVenture Planning GroupApril 20, 2012 197 Pages - SKU: VPG3867656 |
- I. Introduction
- II. Worldwide Market and Technology Overview
- A. Background
- B. Diagnostic Tests
- C. Vaccines and Drugs
- D. Emerging Diagnostic Technologies
- 1. DNA Probes
- a. Technology Overview
- b. Amplification Methods
- 0 Polymerase Chain Reaction
- - Robotics
- - Temperature Cyclers
- - PCR Variations
- 0 Immuno-PCR
- 0 QC-PCR
- 0 DAP-PCR
- 0 Ligase Chain Reaction
- 0 Branched DNA
- 0 Q-Beta Replicase
- 0 Nucleic-Acid Sequence-Based
- 0 Strand Displacement Activation
- 0 Self-Sustained Sequence Replicase
- 2. Monoclonal Antibodies
- 3. Immunoassays
- a. Technological Principle
- b. Enzyme Immunoassays (EIA)
- 0 Overview
- 0 ELISA
- 0 Dot Immunobinding Assays
- 0 Capillary Immunoassays
- 0 Particle-Membrane Capture Immunoassays
- 0 Enzyme Amplificationc. Fluorescent Immunoassays
- 0 Fluorescence Polarization
- 0 Time-Resolved Pulse Fluorescence
- d. Luminescence
- 0 Chemiluminescence
- 0 Bioluminescence
- e. Latex Agglutination
- f. Immunoprecipitation
- 4. Differential Light Scattering
- 5. Microcomputers and Automation
- 6. Artificial Intelligence
- 7. Liposomes
- 8. Flow Cytometry
- 9. Chromatography
- 10. MRI
- 11. Gel Microdroplets
- 12. Other
- III. France: Test Volume and Diagnostics Sales Forecast by Market Segment
- IV. Germany: Test Volume and Diagnostics Sales Forecast by Market Segment
- V. Italy: Test Volume and Diagnostics Sales Forecast by Market Segment
- VI. Japan: Test Volume and Diagnostics Sales Forecast by Market Segment
- VII. Spain: Test Volume and Diagnostics Sales Forecast by Market Segment
- VIII. UK: Test Volume and Diagnostics Sales Forecast by Market Segment
- IX. USA: Market Size, Growth and Major Suppliers’ Sales and Market Shares
- X. Alternative Market Penetration Strategies
- A. Internal Development
- B. Collaborative ArrangementsC. University Contracts
- D. Distribution Strategies for Decentralized Testing Markets
- 1. Marketing Approaches
- 2. Product Complexity
- 3. Customer Preference
- 4. Established Suppliers
- 5. Emerging Suppliers
- 6. Major Types of Distributors
- 7. Market Segmentation
- XI. Potential Market Entry Barriers and Risks
- A. Market Maturity
- B. Cost Containment
- C. Competition
- D. Technological Edge and Limitations
- E. Patent Protection
- F. Regulatory Constraints
- G. Decentralized Testing Market Challenges
- XII. Competitive Assessments
- - Abbott
- - Affymetrix
- - Applera
- - Beckman Coulter
- - Becton Dickinson
- - Binding Site
- - Biomerica
- - Biokit
- - bioMerieux
- - Bio-Rad
- - Biotrol
- - Biosite
- - Biotest
- - Caliper Technologies
- - Cepheid
- - Chemicon
- - Daiichi
- - DiaSorin- Diagast
- - Diamedix
- - Digene
- - Eiken
- - Enzo Biochem
- - Fujirebio
- - GenBio
- - Gene-Tec
- - Hemagen
- - Immunetics
- - Innogenetics
- - Inverness
- - J&J
- - Meridian
- - Nanogen
- - Nissui
- - Olympus
- - Provalis
- - Roche
- - Saliva Diagnostic
- - SeraCare
- - Siemens
- - Third Wave Technologies
- - Thermo Fisher
- - Tosho
- - Trinity Biotech
- - Tropix
- - Wampole Labs
- - Zenith
- - Zeus
- List of Tables
- France Rabies Test Volume and Diagnostics Sales Forecast by Market Segment
- Germany Rabies Test Volume and Diagnostics Sales Forecast by Market Segment
- Italy Rabies Test Volume and Diagnostics Sales Forecast by Market Segment
- Japan Rabies Test Volume and Diagnostics Sales Forecast by Market Segment
- Spain Rabies Test Volume and Diagnostics Sales Forecast by Market Segment
- U.K. Rabies Test Volume and Diagnostics Sales Forecast by Market Segment
- U.S.A. Rabies Test Volume and Diagnostics Sales Forecast by Market Segment
- U.S.A. Rabies Testing Market Diagnostics Sales by Major Supplier
Research assistance
We can help you find what you need. Call us or write us: Need help in your search?
US: 800.298.5699
Int'l: +1.240.747.3093
Related Markets
Diagnostics Reports
- Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Coagulation, Psychiatric Disorders, Tumor Markers, Molecular Blood Typing and Other Testing)
- 2013 Drugs of Abuse Testing in Europe: Hospitals, Commercial Labs, Physician Offices, Ambulatory Care Centers
- 2013 Drugs of Abuse Testing in the US: Hospitals, Commercial Labs, Physician Offices
- 2013 Drugs of Abuse Testing in the UK: Hospitals and Commercial Labs
- 2013 Drugs of Abuse Testing in Spain: Hospitals, Commercial Labs, Ambulatory Care Centers
